At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 49 enrolled
Drug / intervention
Intranasal fentanyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of Intranasal Fentanyl Versus Placebo as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage in the Emergency
In Brief
A Phase 3 clinical trial evaluating Intranasal fentanyl and Placebo for Abscess. Completed, enrolled 49 participants across 1 site.
Detailed Summary
This randomized clinical trial aims to compare the analgesic efficacy of intranasal fentanyl to placebo as analgesic adjunct to conventional local anesthesia for the treatment of pain of the overall procedure in adult patients undergoing lidocaine infiltration and subsequent abscess incision and drainage in the Emergency Department (ED).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbscess
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartAug 2019
Primary CompletionDec 2022
TodayJul 2026
First PostedMar 13, 2019
Enrollment StartAug 1, 2019
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 7.3 years ago
Interventions
Intranasal fentanyldrug
Fentanyl Citrate
Placebodrug
Sterile Water Up to 5Cc